Martin Mendoza, Ph. D

Martin Mendoza, serves as the Director of Extramural Research for the Office of Minority Health (OMH), Office of the Commissioner, FDA.  As director of OMH’s extramural research program, Dr. Mendoza oversees all OMH extramural research which includes projects in the FDA Centers of Excellence in Regulatory Science and Innovation (CERSI) cooperative agreements with Johns Hopkins University, the University of Maryland, Stanford University, the University of California San Francisco, Yale University, and Mayo Clinic. Dr. Mendoza has spoken before Congress in support of OMH’s programs and mission, has authored numerous Congressionally-mandated reports, and is also the primary author for OMH’s recent FDA guidance document Collection of Race and Ethnicity Data in Clinical Trials. Prior to joining the FDA, Dr. Mendoza spent several years in the Office of Clinical Research at the National Institute of Neurological Disorders and Stroke (NINDS), NIH.